We're targeting the $2B powered surgical stapling market with a modular powered platform technology that removes the barrier to adopt reusables by eliminating the need for cleanining and sterilization between procedures. This approach enables us to reuse the costly, complex components and offer substantial savings while satisfying the unmet needs of the patient, surgeon and key stakeholders in the value chain. The RevMedica team has broad and deep experience in all aspects of stapling devices.
Investors 3
Mentions in press and media 2
| Date | Title | Description |
| 15.05.2019 | MassChallenge Boston Announces 2019 Cohort | 100+ high-impact companies to access global network of support and resources in Boston BOSTON, MAY 15, 2019 - MassChallenge, a global network of zero-equity startup accelerators, today announced the more than 100 early-stage startups that ... |
| - | Revmedica | “Home | revmedica” |